Report Detail

Other Global Post Herpetic Neuralgia Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3651436
  • |
  • 07 August, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Scope of the Report:
The global Post Herpetic Neuralgia Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Post Herpetic Neuralgia Therapies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Post Herpetic Neuralgia Therapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Post Herpetic Neuralgia Therapies market by product type and applications/end industries.

Market Segment by Companies, this report covers
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Drugs
Patches
Steroid Injectable

Market Segment by Applications, can be divided into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies


Table of Contents

    1 Post Herpetic Neuralgia Therapies Market Overview

    • 1.1 Product Overview and Scope of Post Herpetic Neuralgia Therapies
    • 1.2 Classification of Post Herpetic Neuralgia Therapies by Types
      • 1.2.1 Global Post Herpetic Neuralgia Therapies Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Types in 2018
      • 1.2.3 Drugs
      • 1.2.4 Patches
      • 1.2.5 Steroid Injectable
    • 1.3 Global Post Herpetic Neuralgia Therapies Market by Application
      • 1.3.1 Global Post Herpetic Neuralgia Therapies Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital Pharmacies
      • 1.3.3 Online Pharmacies
      • 1.3.4 Retail Pharmacies
    • 1.4 Global Post Herpetic Neuralgia Therapies Market by Regions
      • 1.4.1 Global Post Herpetic Neuralgia Therapies Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Post Herpetic Neuralgia Therapies Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Post Herpetic Neuralgia Therapies (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Endo Pharmaceuticals
      • 2.1.1 Business Overview
      • 2.1.2 Post Herpetic Neuralgia Therapies Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Depomed
      • 2.2.1 Business Overview
      • 2.2.2 Post Herpetic Neuralgia Therapies Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Acorda Therapeutics
      • 2.3.1 Business Overview
      • 2.3.2 Post Herpetic Neuralgia Therapies Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Pfizer
      • 2.4.1 Business Overview
      • 2.4.2 Post Herpetic Neuralgia Therapies Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Mylan
      • 2.5.1 Business Overview
      • 2.5.2 Post Herpetic Neuralgia Therapies Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Daiichi Sankyo
      • 2.6.1 Business Overview
      • 2.6.2 Post Herpetic Neuralgia Therapies Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Teikoku Pharma
      • 2.7.1 Business Overview
      • 2.7.2 Post Herpetic Neuralgia Therapies Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Post Herpetic Neuralgia Therapies Market Competition, by Players

    • 3.1 Global Post Herpetic Neuralgia Therapies Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Post Herpetic Neuralgia Therapies Players Market Share
      • 3.2.2 Top 10 Post Herpetic Neuralgia Therapies Players Market Share
    • 3.3 Market Competition Trend

    4 Global Post Herpetic Neuralgia Therapies Market Size by Regions

    • 4.1 Global Post Herpetic Neuralgia Therapies Revenue and Market Share by Regions
    • 4.2 North America Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 4.5 South America Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)

    5 North America Post Herpetic Neuralgia Therapies Revenue by Countries

    • 5.1 North America Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
    • 5.2 USA Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)

    6 Europe Post Herpetic Neuralgia Therapies Revenue by Countries

    • 6.1 Europe Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
    • 6.2 Germany Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 6.3 UK Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 6.4 France Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Countries

    • 7.1 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
    • 7.2 China Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 7.5 India Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)

    8 South America Post Herpetic Neuralgia Therapies Revenue by Countries

    • 8.1 South America Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
    • 8.2 Brazil Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Post Herpetic Neuralgia Therapies by Countries

    • 9.1 Middle East and Africa Post Herpetic Neuralgia Therapies Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Post Herpetic Neuralgia Therapies Revenue and Growth Rate (2014-2019)

    10 Global Post Herpetic Neuralgia Therapies Market Segment by Type

    • 10.1 Global Post Herpetic Neuralgia Therapies Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Type (2019-2024)
    • 10.3 Drugs Revenue Growth Rate (2014-2024)
    • 10.4 Patches Revenue Growth Rate (2014-2024)
    • 10.5 Steroid Injectable Revenue Growth Rate (2014-2024)

    11 Global Post Herpetic Neuralgia Therapies Market Segment by Application

    • 11.1 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Application (2014-2019)
    • 11.2 Post Herpetic Neuralgia Therapies Market Forecast by Application (2019-2024)
    • 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
    • 11.4 Online Pharmacies Revenue Growth (2014-2019)
    • 11.5 Retail Pharmacies Revenue Growth (2014-2019)

    12 Global Post Herpetic Neuralgia Therapies Market Size Forecast (2019-2024)

    • 12.1 Global Post Herpetic Neuralgia Therapies Market Size Forecast (2019-2024)
    • 12.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Regions (2019-2024)
    • 12.3 North America Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
    • 12.4 Europe Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
    • 12.6 South America Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Post Herpetic Neuralgia Therapies Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Post Herpetic Neuralgia Therapies . Industry analysis & Market Report on Post Herpetic Neuralgia Therapies is a syndicated market report, published as Global Post Herpetic Neuralgia Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Post Herpetic Neuralgia Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,773.56
      4,160.34
      5,547.12
      3,236.40
      4,854.60
      6,472.80
      532,022.40
      798,033.60
      1,064,044.80
      290,336.40
      435,504.60
      580,672.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report